Will Poison Pill Squash American Apparel’s Stock Price?

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

blue jeans
Thinkstock
Saying that it will strengthen the company’s ability to protect stockholders, American Apparel Inc. (NYSE: APP) announced on Saturday that the company has adopted a one-year stockholder rights plan. The plan is the direct result of a lawsuit threatened by fired chairman and CEO Dov Charney in order to regain control of the company he founded.

According to the company’s press release, the poison pill was adopted as a response to:

… reports of rapid accumulations of the Company’s outstanding common stock. The rights plan is designed to limit the ability of any person or group, including Dov Charney, to seize control of the Company without appropriately compensating all American Apparel stockholders. … It does not affect trading by passive investors, as it allows such investors to accumulate as much as 15% of the Company’s common stock and has no impact on a takeover proposal for the entire company acceptable to the holders of a majority of the Company’s shares.

The stockholder rights plan takes effect if any shareholder who already holds 15% or more of the company’s stock tries to accumulate more. Charney owns 27% of American Apparel’s outstanding shares and said on Friday that he was looking to acquire another 10%.

Sensing a possible battle for control, investors piled into American Apparel’s stock in the last half hour of trading on Friday, pushing the share price from $0.77 to close at $0.97, nearly a 30% gain for the day.

American Apparel’s stock has more than doubled since posting a 52-week low of $0.46 on April 8. The stock nearly doubled from a low of $0.51 just last Wednesday. Shares dipped last week when Charney said he would fight to get his job back. Then they rose when the company said it had hired a firm to help it raise cash, and shares really took off at the end of the day Friday as a battle for control looms.

Our guess is that Monday’s opening bid will show another dip following the adoption of the poison pill. The stock’s 52-week range is $0.46 to $2.09, and more than 24 million shares were traded on Friday, about five times more than the daily average.

ALSO READ: Four Retail Stocks to Sell and Avoid

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618